Related Experiment Video
Updated: Nov 17, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Neural signaling modulates metabolism of gastric cancer
Hanne-Line Rabben1,2, Gøran Troseth Andersen1, Magnus Kringstad Olsen1
1Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway.
Abstract:
Tumors comprise cancer cells and the associated stromal and immune/inflammatory cells, i.e., tumor microenvironment (TME). Here, we identify a metabolic signature of human and mouse model of gastric cancer and show that vagotomy in the mouse model reverses the metabolic reprogramming, reflected by metabolic switch from glutaminolysis to OXPHOS/glycolysis and normalization of the energy metabolism in cancer cells and TME. We next identify and validate SNAP25, mTOR, PDP1/α-KGDH, and glutaminolysis as drug targets and accordingly propose a therapeutic strategy to target the nerve-cancer metabolism. We demonstrate the efficacy of nerve-cancer metabolism therapy by intratumoral injection of BoNT-A (SNAP25 inhibitor) with systemic administration of RAD001 and CPI-613 but not cytotoxic drugs on overall survival in mice and show the feasibility in patients. These findings point to the importance of neural signaling in modulating the tumor metabolism and provide a rational basis for clinical translation of the potential strategy for gastric cancer.
Insights
Targeting nerve-cancer metabolism reverses gastric cancer progression. This study identifies key metabolic targets and demonstrates a novel therapeutic strategy combining vagotomy with specific inhibitors, showing promise for patient treatment.
Area of Science:
- Oncology
- Metabolic Research
- Cancer Biology
Background:
- Tumors are complex ecosystems involving cancer cells and the tumor microenvironment (TME).
- Gastric cancer exhibits specific metabolic reprogramming, crucial for its growth and survival.
Purpose of the Study:
- To identify the metabolic signature of gastric cancer.
- To investigate the effect of vagotomy on metabolic reprogramming in gastric cancer.
- To propose and validate a novel therapeutic strategy targeting nerve-cancer metabolism.
Main Methods:
- Metabolic profiling of human and mouse gastric cancer models.
- Vagotomy intervention in mouse models to assess metabolic changes.
- Identification and validation of drug targets including SNAP25, mTOR, PDP1/α-KGDH, and glutaminolysis.
- Therapeutic efficacy assessment using intratumoral BoNT-A with systemic RAD001 and CPI-613 in mice.
Main Results:
- Vagotomy reversed metabolic reprogramming in gastric cancer, shifting from glutaminolysis to OXPHOS/glycolysis.
- Normalization of energy metabolism in cancer cells and the TME was observed post-vagotomy.
- Combined therapy (BoNT-A, RAD001, CPI-613) significantly improved overall survival in mice.
- The proposed therapeutic strategy demonstrated feasibility in patients.
Conclusions:
- Neural signaling plays a critical role in modulating tumor metabolism in gastric cancer.
- Targeting nerve-cancer metabolism represents a promising therapeutic avenue.
- This study provides a rationale for the clinical translation of this novel strategy for gastric cancer treatment.
Related Concept Videos
Regulation of Food Intake
Neural Regulation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Hormonal Regulation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

